• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DAVIS & GECK CARIBE LTD CAPROSYN; SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC AC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DAVIS & GECK CARIBE LTD CAPROSYN; SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC AC Back to Search Results
Model Number SC-543
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/03/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that during a c-section surgery, the six sutures strand broke in the middle when tension was applied to tighten the knot.The issue was resolved by using another suture from a different lot number.No patient complications have been reported as a result of this event.
 
Additional Manufacturer Narrative
D10 concomitant product: sc-543, sc-543 caprosyn 3-0 und 75cm sc1 x36 (lot#: d3j3125y); sc-543, sc-543 caprosyn 3-0 und 75cm sc1 x36 (lot#: d3j3125y); sc-543, sc-543 caprosyn 3-0 und 75cm sc1 x36 (lot#: d3j3125y); sc-543, sc-543 caprosyn 3-0 und 75cm sc1 x36 (lot#: d3j3125y); sc-543, sc-543 caprosyn 3-0 und 75cm sc1 x36 (lot#: d3j3125y); sc-543, sc-543 caprosyn 3-0 und 75cm sc1 x36 (lot#: d3j3125y); sc-543, sc-543 caprosyn 3-0 und 75cm sc1 x36 (lot#: d4a3772y); sc-543, sc-543 caprosyn 3-0 und 75cm sc1 x36 (lot#: d3j3125y).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Additional information: g3, h3, h6 h3 evaluation summary: medtronic conducted an investigation based upon all information received.The device was available for evaluation.The visual inspection of the returned product (opened samples) noted that two of the sutures were returned broken.Suture a broke 27 1/2 inches from the needle attachment point.Suture b broke 2 7/8 inches from the needle attachment point.A tensile strength test could not be performed on the open samples.The tensile strength of absorbable sutures may be affected by degradation of the suture and/or damage during use after the product has been opened and may impact the validity of any test results.It was reported that suture was broken.The reported issue was confirmed.The most likely cause could not be established from the information available.Internal process improvements have been initiated to mitigate this issue.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.The instructions included with this device provide the following guidance: progressive loss of tensile strength and eventual absorption of the absorbable sutures occurs by means of hydrolysis.This loss is triggered when exposed to the environment or clinical application.Damage during use may result in inadequate sample length to perform testing and/or deformation of the suture contributing to a loss in tensile strength.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPROSYN
Common Device Name
SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC AC
Manufacturer (Section D)
DAVIS & GECK CARIBE LTD
zona franca de san isidro
santo domingo 0101
DR  0101
Manufacturer (Section G)
DAVIS & GECK CARIBE LTD
zona franca de san isidro
santo domingo 0101
DR   0101
Manufacturer Contact
mike bocchino
8200 coral sea st ne
mounds view, MN 55112-4391
8006464633
MDR Report Key22665336
Report Number9612501-2025-02073
Device Sequence Number20704585
Product Code GAM
UDI-Device Identifier10884521034709
UDI-Public(01)10884521034709(17)260831(10)D3J3125Y(20)01
Combination Product (Y/N)N
Initial Reporter CountryDA
PMA/510(K) Number
K032586
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 10/10/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/31/2026
Device Model NumberSC-543
Device Catalogue NumberSC-543
Device Lot NumberD3J3125Y
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/21/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/04/2025
Supplement Date Received by Manufacturer10/09/2025
Initial Report FDA Received Date07/30/2025
Supplement Report FDA Received Date10/10/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/22/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-